Cargando…
The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease
Parkinson’s disease is the second most common neurodegenerative disorder; it affects 1% of the population over the age of 65. The number of people with Parkinson’s disease is set to rapidly increase due to changing demographics and there is an unmet clinical need for disease-modifying therapies. The...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059567/ https://www.ncbi.nlm.nih.gov/pubmed/31997802 http://dx.doi.org/10.4103/1673-5374.274327 |